RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: DYSPNOEA

20260101 - 20261231

No. 1 - 100

Next page: 2 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
1
26555302
US
Vision blurred, Swelling, Arthralgia, Systemic lupus erythematosus, Blood creatinine increased, Blood pressure increased, Fluid retention, Dyspnoea, Exposure during pregnancy,
AZATHIOPRINE, VOCLOSPORIN, VOCLOSPORIN, HYDROXYCHLOROQUINE SULFATE, BELIMUMAB,
2
26555389
US
 1
Oxygen saturation decreased, Dyspnoea, Cough, Asthenia, Wrong technique in device usage process, Drug ineffective, Product complaint,
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE,
3
26555420
CA
 63
Adverse drug reaction, Asthma, Blood immunoglobulin E increased, Chest discomfort, Chronic sinusitis, Dysphonia, Dyspnoea, Emotional distress, Eosinophilia, Ill-defined disorder, Laryngeal dyskinesia, Laryngeal stenosis, Loss of personal independence in daily activities, Middle insomnia, Muscle spasms, Obstructive airways disorder, Sinus disorder, Skin lesion, Wheezing, Sleep disorder, Cough,
BUDESONIDE, CICLESONIDE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, PANTOPRAZOLE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, VALACYCLOVIR HYDROCHLORIDE, ALBUTEROL SULFATE,
4
26555490
US
 56 1
Cardiac disorder, Dyspnoea,
5
26555522
US
 1
Hospitalisation, Dyspnoea, Therapy change, Device use issue, Product dose omission issue,
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,
6
26555536
EU
 59
Lymphoma, Testicular neoplasm, Richter^s syndrome, Submandibular gland enlargement, Dysphonia, Stress, General physical health deterioration, Pain in extremity, Night sweats, Dyspnoea, Dyspnoea, Asthenia, Off label use,
RITUXIMAB, VENETOCLAX, PIRTOBRUTINIB,
7
26555604
US
Oxygen saturation decreased, Hypertension, Chest discomfort, Pyrexia, Dyspnoea, Flushing,
DONANEMAB-AZBT, DONANEMAB-AZBT,
8
26555605
US
 46 2
Erythema, Dyspnoea, Pruritus, Injection site pruritus, Injection site erythema,
TIRZEPATIDE,
9
26555616
CA
 1
General physical health deterioration, Dyspnoea,
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN,
10
26555646
US
 80 2
Dyspnoea, Peripheral swelling,
TREPROSTINIL, TREPROSTINIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AMLODIPINE BESYLATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, POLYETHYLENE GLYCOL 3350, FUROSEMIDE, BIOTIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, OXYGEN, 0XYGEN, MONTELUKAST SODIUM, MONTELUKAST, GABAPENTIN, TIRZEPATIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM,
11
26555758
47 1
Hypoaesthesia, Headache, Chest pain, Dyspnoea, Heart rate increased,
TIRZEPATIDE,
12
26555776
US
 63 2
Syncope, Pain in extremity, Dyspnoea, Rhinorrhoea, Dizziness, Weight increased,
SOTATERCEPT-CSRK,
13
26555902
US
 37
Disturbance in attention, Dyspnoea, Migraine, Hypoaesthesia, Asthenia, Headache, Malaise, Dizziness, Discomfort, Anxiety, Drug ineffective, Incorrect route of product administration,
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A,
14
26555960
CA
 65 2
Pneumonia, Vomiting, Asthma, Dyspnoea, Oedema, Wheezing, Drug hypersensitivity,
FLUTICASONE PROPIONATE, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE,
15
26556031
SG
 72 2
Death, Dyspnoea, Pneumonia,
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF,
16
26556046
US
 2
Urticaria, Dyspnoea, Fatigue, Off label use,
OMALIZUMAB, OMALIZUMAB, FLUOXETINE HYDROCHLORIDE,
17
26556047
US
 65 2
Heart rate irregular, Dyspnoea,
NIPOCALIMAB,
18
26556076
GB
 70 2
Peripheral swelling, Joint swelling, Dyspnoea,
RAMIPRIL, NITROGLYCERIN, INSULIN HUMAN, AMLODIPINE, AZATHIOPRINE, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CYANOCOBALAMIN, RANOLAZINE, LANSOPRAZOLE, RIVAROXABAN, EMPAGLIFLOZIN, FUROSEMIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG,
19
26556101
US
Dyspnoea,
INSULIN HUMAN,
20
26556193
US
 46
Fatigue, Dyspnoea, Laboratory test abnormal, Memory impairment,
BREXUCABTAGENE AUTOLEUCEL,
21
26556462
CA
 44
Pulmonary embolism, Back pain, Chest pain, Dyspnoea, Pyrexia, Off label use,
INFLIXIMAB,
22
26556688
CA
 63 2
Alopecia, Application site reaction, Chronic spontaneous urticaria, Depression, Dyspnoea, Dyspnoea exertional, Haemorrhage, Headache, Hepatic enzyme increased, Urticaria, Tachycardia, Insomnia, Intervertebral disc protrusion, Malaise, Middle insomnia, Muscular weakness, Pain, Paraesthesia, Primary biliary cholangitis, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Erythema, Product dose omission issue, Drug ineffective, Incorrect dose administered, Inappropriate schedule of product administration, Wrong technique in product usage process,
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX,
23
26556758
US
 78 2
Red blood cell count decreased, Dyspnoea, Chronic obstructive pulmonary disease, Pulmonary arterial hypertension, Dyspnoea exertional, Chest pain, Dizziness, Joint swelling,
DUPILUMAB, AMBRISENTAN, SOTATERCEPT-CSRK,
24
26556768
CA
 77 1
Cataract, Dyspnoea, Cough, Sputum discoloured, Condition aggravated, Cardiac disorder,
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, PREDNISONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PREDNISONE,
25
26556780
US
 2
Dyspnoea, Circumstance or information capable of leading to medication error,
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE,
26
26556852
US
 68 1
Portal venous gas, Off label use, Dyspnoea, Leukocytosis, Abdominal distension, Abdominal pain,
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, APIXABAN,
27
26556896
IN
Intentional overdose, Compartment syndrome, Reperfusion injury, Dyspnoea, Peripheral ischaemia, Haemodynamic instability, Condition aggravated,
AMLODIPINE,
28
26556931
US
 2
Fluid retention, Dyspnoea,
RISANKIZUMAB-RZAA, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FUROSEMIDE, ISOSORBIDE MONONITRATE, NITROGLYCERIN, POTASSIUM CHLORIDE,
29
26557014
GB
 53 1
Dyspnoea,
AMLODIPINE BESYLATE, QUETIAPINE FUMARATE, QUETIAPINE, DOXAZOSIN, DOXAZOSIN MESYLATE, MIRTAZAPINE, MIRTAZAPINE, CARBAMAZEPINE, LITHIUM, LITHIUM BROMATUM,
30
26557023
GB
 38 2
Dyspnoea,
QUETIAPINE FUMARATE, QUETIAPINE,
31
26557062
GB
 2
Dyspnoea,
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL,
32
26557072
EU
 31 2
Saliva altered, Retching, Mouth swelling, Dyspnoea, Fatigue,
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE,
33
26557077
EU
 1
Erythema, Lip erythema, Tongue erythema, Cough, Dyspnoea,
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CANDESARTAN, DOXEPIN, DOXEPIN HYDROCHLORIDE,
34
26557158
CA
 60 1
Neuropathy peripheral, Cough, Dyspnoea, Asthma, Full blood count abnormal, Visual impairment, Paraesthesia, Eosinophil count increased, Product use in unapproved indication, Productive cough, Malaise, Gastrooesophageal reflux disease, Hypoaesthesia, Disease recurrence, Therapeutic product effect incomplete, Haemoptysis, Eosinophilic granulomatosis with polyangiitis, Upper respiratory tract infection, Drug dependence, Vasculitis,
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, BUDESONIDE, BUDESONIDE, BUDESONIDE, RANIBIZUMAB, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRROLATE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG,
35
26557299
US
 1
Headache, Dyspnoea,
SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE,
36
26557312
US
 73 2
Urticaria, Dyspnoea,
DUPILUMAB,
37
26557337
US
 2
Dyspnoea, Nausea,
QUETIAPINE FUMARATE, QUETIAPINE,
38
26557355
US
Headache, Dyspnoea, Intraocular pressure increased,
AFLIBERCEPT,
39
26557389
Dyspnoea, Fall, Lower respiratory tract infection, Dementia Alzheimer^s type, Urinary tract infection, Weight decreased, Product dose omission issue,
CERTOLIZUMAB PEGOL,
40
26557397
US
 50 2
Loss of personal independence in daily activities, Dyspnoea, Headache, Product dose omission in error,
DUPILUMAB,
41
26557403
US
 40 2
Upper respiratory tract infection, Dyspnoea, Nasal polyps, Nasal congestion,
DUPILUMAB,
42
26557426
US
 61 2
Secretion discharge, Dyspnoea,
DUPILUMAB,
43
26557497
US
 41 2
Asthma, Dyspnoea,
DUPILUMAB,
44
26557518
GB
 69 1
Arrhythmia, Palpitations, Dyspnoea, Tremor, Dizziness, Thirst,
DAPAGLIFLOZIN, RAMIPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BEMPEDOIC ACID,
45
26557543
US
 76 2
Dyspnoea,
DUPILUMAB,
46
26557550
29
Arrhythmia, Sensation of foreign body, Dyspnoea, Chest discomfort, Nausea, Rash,
47
26557569
US
 75 2
Bronchitis, Dyspnoea, Blood glucose increased, Off label use,
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN LISPRO,
48
26557593
US
 34 1
Dyspnoea,
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,
49
26557598
US
 64 2
Dyspnoea, Product dose omission issue, Pruritus,
DUPILUMAB,
50
26557629
US
 70 2
Dyspnoea, Injection site pain,
DUPILUMAB,
51
26557670
IN
Migraine, Headache, Dyspnoea, Multiple sclerosis relapse,
OCRELIZUMAB,
52
26557683
US
Dyspnoea, Chest discomfort, Paraesthesia, Nausea,
BOTULINUM TOXIN TYPE A,
53
26557687
EU
 80 1
Cardiac failure, Haemorrhage, Tremor, Pleural effusion, Insomnia, Cough, Pyrexia, Back pain, Constipation, Dyspnoea, Diarrhoea, Oliguria,
IXAZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACYCLOVIR, ALLOPURINOL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG,
54
26557707
US
Dyspnoea, Product use issue, Device delivery system issue,
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE,
55
26557819
US
 62
Loss of consciousness, Heart rate decreased, Blood glucose decreased, Injection site discolouration, Throat tightness, Eye swelling, Injection site swelling, Injection site erythema, Injection site pruritus, Dyspnoea, Injection site pain, Off label use,
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A,
56
26557832
US
Dyspnoea, Hyperhidrosis, Chest pain, Nausea, Back pain, Flushing,
FERRIC DERISOMALTOSE,
57
26557939
US
 47 2
Sneezing, Nasal congestion, Headache, Lacrimation increased, Dyspnoea,
TIRZEPATIDE,
58
26557981
US
 71 1
Dyspnoea, Injection site pain,
DUPILUMAB,
59
26558016
JP
 2
Diarrhoea, Gastric ulcer, Gastric cancer, Haemoglobin decreased, Decreased appetite, Weight decreased, Dyspnoea, Malaise,
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, DOCETAXEL, DOCETAXEL ANHYDROUS,
60
26558023
US
 1
Sleep disorder, Dyspnoea, Product dose omission issue,
DUPILUMAB, AZELASTINE HYDROCHLORIDE, AZELASTINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,
61
26558103
US
 79 2
Sinus disorder, Nasopharyngitis, Hypersensitivity, Dyspnoea,
TADALAFIL, AMBRISENTAN, TREPROSTINIL,
62
26558150
US
 48 2
Fluid retention, Pleural effusion, Abdominal distension, Dyspnoea, Weight increased,
DUPILUMAB,
63
26558300
2
Asthenia, Dyspnoea,
LORATADINE,
64
26558370
US
Dyspnoea, Product use complaint,
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE,
65
26558389
US
 78 1
Dyspnoea,
LENALIDOMIDE,
66
26558394
CN
 78 2
Anaphylactic shock, Eyelid oedema, Conjunctival oedema, Erythema, Pruritus, Chest discomfort, Tachypnoea, Dizziness, Blood pressure decreased, Heart rate increased, Dyspnoea, Rash,
TOBRAMYCIN,
67
26558424
US
Flushing, Chest pain, Dyspnoea,
FERRIC DERISOMALTOSE,
68
26558456
EU
 2
Oxygen saturation decreased, Dyspnoea exertional, Dyspnoea,
AMIKACIN,
69
26558487
US
Pharyngeal swelling, Chest discomfort, Dyspnoea, Nasal congestion, Fatigue, Urticaria, Nausea, Headache,
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, LEVOCETIRIZINE DIHYDROCHLORIDE, PYRIDOSTIGMINE BROMIDE, FAMOTIDINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, KETOTIFEN FUMARATE, BUDESONIDE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VARENICLINE, VORTIOXETINE, CYCLOSPORINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVALBUTEROL TARTRATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MEPOLIZUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ICATIBANT, LEVALBUTEROL HYDROCHLORIDE, LANADELUMAB-FLYO,
70
26558632
US
Dyspnoea,
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,
71
26558718
GB
 88 2
Rash, Dyspnoea,
MEMANTINE, MEMANTINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DONEPEZIL HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, PRAMIPEXOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER,
72
26558722
GB
 73 2
Blood glucose decreased, Pleural effusion, Lower respiratory tract infection, Nerve injury, Pain in extremity, Contusion, Pyrexia, Gait inability, Dyspnoea, Burning feet syndrome, Off label use,
TRAMETINIB, TRAMETINIB, DABRAFENIB, DABRAFENIB, MIRTAZAPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE,
73
26558882
CA
 65 2
Pneumonia, Pain, Wheezing, Dyspnoea, Oedema, Nasal oedema, Malaise, Asthma, Cough, Respiratory tract infection, Drug hypersensitivity, Vomiting, Chest pain,
FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ROSUVASTATIN, ROSUVASTATIN, ERGOCALCIFEROL, FLUTICASONE FUROATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, CEFADROXIL, POLYMYXIN B SULFATE,
74
26558921
GB
 82 2
Fatigue, Dyspnoea, Myalgia,
APIXABAN, BUMETANIDE, LISINOPRIL,
75
26558964
GB
 88 2
Rash, Dyspnoea,
MEMANTINE, MEMANTINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DONEPEZIL HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PRAMIPEXOLE,
76
26559142
US
 53 2
Dyspnoea, Device use issue, Product dose omission issue, Incorrect dose administered by device, Device malfunction, Device delivery system issue,
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,
77
26559156
36 2
Dyspnoea,
REPOSITORY CORTICOTROPIN,
78
26559239
GB
 2
Dyspnoea,
SEMAGLUTIDE,
79
26559304
EU
 66
Dyspnoea, Fatigue,
DEGARELIX, GALLIUM GA-68 GOZETOTIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BISOPROLOL FUMARATE, RAMIPRIL, EDOXABAN TOSYLATE, TORSEMIDE, ENZALUTAMIDE,
80
26559361
US
 2
Dyspnoea, Dizziness, Gait disturbance, Fluid retention, Dysstasia, Balance disorder,
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, DAPAGLIFLOZIN, FUROSEMIDE, LATANOPROST, METOPROLOL TARTRATE, METOPROLOL, SIMVASTATIN,
81
26559645
IN
 54 1
Dyspnoea, Ascites,
RAMUCIRUMAB,
82
26559694
US
 71 2
Cardiomyopathy, Fall, Upper limb fracture, Pneumonia, Dyspnoea,
AMLODIPINE BESYLATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CARVEDILOL, FOLIC ACID, GLIPIZIDE, GLIPIZIDE-TABLETS,
83
26559730
US
 72
Pneumonia, Haemoptysis, Lethargy, Oedema peripheral, Peripheral swelling, Contusion, Nail discolouration, Product distribution issue, Dyspnoea exertional, Product dose omission issue, Headache, Dyspnoea,
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL,
84
26559858
56 1
Contrast media allergy, Tachypnoea, Blood pressure decreased, Loss of consciousness, Unresponsive to stimuli, Pulse absent, Apnoea, Oxygen saturation immeasurable, Heart rate abnormal, Pruritus, Dyspnoea, Cyanosis, Conjunctival oedema, Chest discomfort, Erythema, Supraventricular extrasystoles,
IOPROMIDE, IOPROMIDE,
85
26559946
TR
 2
Headache, Dyspnoea,
ECULIZUMAB, ECULIZUMAB,
86
26560053
US
 40 2
Urine output decreased, Abdominal distension, Dyspnoea, Fatigue, Swelling,
SPARSENTAN,
87
26560217
US
 2
Eye pruritus, Eye irritation, Vision blurred, Weight fluctuation, Dyspnoea, Pain, Dry eye,
DUPILUMAB, DUPILUMAB, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE,
88
26560218
US
 80 2
Chronic obstructive pulmonary disease, Dyspnoea, Secretion discharge, Product dose omission issue,
DUPILUMAB, DUPILUMAB,
89
26560265
US
 66 2
Dyspnoea, Pruritus,
DUPILUMAB, DUPILUMAB,
90
26560384
US
 69 1
Dyspnoea,
DUPILUMAB,
91
26560470
US
 59 1
Dyspnoea, Product dose omission issue, Arthralgia, Rash,
DUPILUMAB,
92
26560608
EU
 43 1
Schizophrenia, Social anxiety disorder, Personality disorder, Dyspnoea, Restlessness, Depression, Tremor,
SERTRALINE, OXAZEPAM, OLANZAPINE, OLANZAPINE PAMOATE, ARIPIPRAZOLE,
93
26560661
KW
 54 2
Gait disturbance, Dyspnoea,
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ,
94
26560782
18 1
Cardiac disorder, Throat tightness, Dyspnoea, Speech disorder, Inadequate analgesia, Pain,
NALTREXONE,
95
26560956
US
Gait disturbance, Chest discomfort, Weight increased, Chest pain, Visual impairment, Oedema, Disorientation, Dyspnoea, Constipation, Prescribed underdose, Dizziness,
SPARSENTAN, BUDESONIDE, EVOLOCUMAB, OMEPRAZOLE MAGNESIUM, EMPAGLIFLOZIN, SODIUM ZIRCONIUM CYCLOSILICATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LOSARTAN, METOPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, ALBUTEROL SULFATE, ALBUTEROL, NITROGLYCERIN,
96
26560965
CA
 59 2
Asthma, Chronic obstructive pulmonary disease, Cough, Dyspnoea, Full blood count abnormal, Loss of personal independence in daily activities, Sleep disorder due to a general medical condition, Sputum discoloured, Therapeutic product effect incomplete, Wheezing,
ALBUTEROL SULFATE, ALBUTEROL,
97
26561109
IN
 58 1
Death, Dyspnoea,
LORLATINIB,
98
26561111
EU
 17 2
Dyspnoea, Dizziness, Anxiety, Chest discomfort, Off label use,
METHOTREXATE, METHOTREXATE SODIUM,
99
26561297
KR
 47 2
Diaphragmatic disorder, Dyspnoea, Off label use, Abdominal pain upper, Abdominal discomfort,
TIRZEPATIDE,
100
26561327
US
 1
Dyspnoea,
TIRZEPATIDE,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2026-04-28

Next page: 2 next page>>